XML 55 R44.htm IDEA: XBRL DOCUMENT v3.23.3
Redeemable Noncontrolling Interest - Summary of Net Income Attributable to Vtv Therapeutics Inc (Detail) - USD ($)
$ in Thousands
3 Months Ended 9 Months Ended
Sep. 30, 2023
Sep. 30, 2022
Sep. 30, 2023
Sep. 30, 2022
Noncontrolling Interest [Abstract]        
Net loss attributable to vTv Therapeutics Inc. common shareholders $ (6,654) $ (4,261) $ (16,772) $ (14,419)
Decrease/(Increase) in vTv Therapeutics Inc. accumulated deficit for purchase of vTv LLC Units as a result of common stock issuances 1,592 (1,174) 4,212 (103)
Change from net loss attributable to vTv Therapeutics Inc. common shareholders and transfers to noncontrolling interest $ (5,062) $ (5,435) $ (12,560) $ (14,522)